The conserved SWI/SNF chromatin remodeling complex uses the energy from ATP hydrolysis to alter local chromatin environments through disrupting DNA-histone contacts. These alterations influence transcription activation, as well as repression. The Drosophila SWI/SNF counterpart, known as the Brahma or Brm complex, has been shown to have an essential role in regulating the proper expression of many developmentally important genes, including those required for eye and wing tissue morphogenesis. A temperature sensitive mutation in one of the core complex subunits, SNR1 (SNF5/INI1/SMARCB1), results in reproducible wing patterning phenotypes that can be dominantly enhanced and suppressed by extragenic mutations. SNR1 functions as a regulatory subunit to modulate chromatin remodeling activities of the Brahma complex on target genes, including both activation and repression. To help identify gene targets and cofactors of the Brahma complex, we took advantage of the weak dominant nature of the snr1 E1 mutation to carry out an unbiased genetic modifier screen. Using a set of overlapping chromosomal deficiencies that removed the majority of the Drosophila genome, we looked for genes that when heterozygous would function to either enhance or suppress the snr1 E1 wing pattern phenotype. Among potential targets of the Brahma complex, we identified components of the Notch, EGFR and DPP signaling pathways important for wing development. Mutations in genes encoding histone demethylase enzymes were identified as cofactors of Brahma complex function. In addition, we found that the Lysine Specific Demethylase 1 gene (lsd1) was important for the proper cell type-specific development of wing patterning.
Introduction
Within the eukaryotic cell nucleus, chromosomal DNA is first packaged into nucleosomes that are further assembled into a highly structured nucleoprotein complex called chromatin. Chromatin organization is a fundamental constraint involved in regulating the expression of eukaryotic genes, since the presence of a nucleosome around a binding site blocks the accessibility of most transcription factors to their cognate binding sequences. The highly conserved SWI/ SNF ATP-dependent chromatin remodeling complex regulates the expression of many genes by remodeling chromatin in response to regulatory signals, thus enabling the binding of transcription factors and activator complexes to regulatory sequences within target genes.
SWI/SNF complexes play critical roles in DNA replication and repair, RNA Polymerase II transcription, as well as metazoan embryonic development and postnatal tissue regeneration by regulating cell proliferation, differentiation and survival (Mohrmann and Verrijzer, 2005; Wu et al., 2009) . Components of the complex were first identified in yeast during two independent genetic screens as mutants that either lost the ability to switch mating type (SWI for Switching Deficient) or displayed an inability to grow in sucrose containing medium (SNF for Sucrose non-fermenting) (Winston and Carlson, 1992) . The yeast and metazoan SWI/SNF complexes are composed of 8-11 unique subunits with an approximate molecular mass of 1.2 MDa (Peterson et al., 1994; Smith et al., 2003) . The complex has a single ATPase subunit that is required both in vitro and in vivo for ATP-dependent chromatin remodeling activity. However, full in vitro chromatin remodeling activity on mono-nucleosomes and nucleosomal arrays can be achieved with reconstitution of 4 mammalian "core" subunits, BRG1, INI1/BAF47, BAF170, and BAF155 (Phelan et al., 1999) , making it likely that the remaining subunits are important for complex stability, regulation, and/or targeting.
The Drosophila SWI/SNF counterpart is known as the Brahma (Brm) complex. The chromatin remodeling activities of the Brm complex are important for both the activation and repression of gene transcription during development (Simon and Tamkun, 2002) . The BRM protein co-localizes with RNA Polymerase II on salivary gland polytene chromosomes within regions undergoing active gene transcription (Armstrong et al., 2002; Zraly et al., 2003) . Microarray analyses of Brm complex mutants demonstrated that the complex was likely involved in both transcription activation and repression (Zraly et al., 2006) . The role of Brm complex regulation during gene activation has been extensively characterized and often involves recruitment of histone modifying enzymes, such as histone acetyltransferases (HATs), and gene specific transcription factors (Simon and Tamkun, 2002) . The role of the Brm complex in gene repression is less well understood, and is generally thought to result from the formation of repressive chromatin within gene promoters or through associations with co-repressor complexes including histone deacetylases and demethylases.
SNF5 is a core component of all purified SWI/SNF complexes and serves an essential function in regulating chromatin remodeling activities. Previous work demonstrated that a dominant negative mutation in the Drosophila snr1 gene (snr1
E1
) that encodes a core Brm subunit, SNF5-Related-1 (SNR1), leads to differential misregulation of genes required for wing vein and inter-vein cell development , suggesting possible regulatory targets for the Brm complex in vivo that include components of the EGFR (Epidermal Growth Factor Receptor), DPP/BMP (Decapapentaplegic/Bone Morphogenetic Protein) and Notch-Delta signaling pathways. These studies revealed tissue-specific differential requirements for Brm complex functions in patterning and allowed us to conclude the following: (i) The ectopic veins associated with snr1 E1 are dependent on BRM ATPase chromatin remodeling activity; (ii) SNR1 functions to regulate BRM ATPase activity on specific gene targets (e.g., rhomboid) in intervein cells of the wing through collaborations with transcriptional repressors (e.g., NET) and histone deacetylase (HDAC) activity. These studies revealed that transcription repression by the Brm complex is due in part to restraint of chromatin remodeling activities and that the SNR1 subunit has regulatory role to restrict remodeling activities in a cell-type, tissue-specific manner . We sought to further address how target genes are selectively regulated by the Brm complex through studies of SNR1 function, as this subunit plays a pivotal role in complex dependent gene-specific repression. There are two possible mechanisms of SNR1 mediated complex regulation: (i) physical associations between individual subunits within the complex and (ii) physical association between the Brm complex and other coregulatory proteins. We addressed both of these possibilities and observed an important genetic and physical interaction between two Brm complex core subunits, SNR1 and MOR. Specifically, we found that the highly conserved SNR1 Repeat 2 (R2) and Coiled-coil regions physically associate with the SWIRM domain of MOR. Employing a dominant enhancer-suppressor genetic screen we also identified histone lysine demethylase enzymes as potential coregulators of Brm complex remodeling activities. We found that Lysine Specific Demethylase-1 (LSD1) genetically and physically associates with the Brm complex. Further, lsd1 appears to genetically interact with a subtype of the Brm complex (Polybromo or PBAP) in the context of wing development. Lastly, we show that LSD1 is expressed throughout the pupal wing, in both vein and intervein cells, and that it likely functions in a cell-type specific fashion to repress highly conserved EGFR and/or DPP signaling in intervein cells.
Materials and methods

Fly stocks and genetic analyses
All Drosophila stocks were maintained on standard yeast/cornmeal/dextrose medium at 25°C, except for snr1 E1 ,e/TM6B,Hu,e which was maintained at 29°C. Mutant strains were obtained from private stocks and the Indiana University-Bloomington Drosophila Stock Center (BDSC, Bloomington, Indiana). Transgenic RNAi lines were obtained from the Vienna Drosophila Resource Center (Vienna, Austria). All strains and gene mutants are described in detail in Flybase (http://flybase.bio.indiana.edu).
Drosophila chromosomal deficiency stocks were obtained from the BDSC. Information on the deficiency stocks tested and predicted/ known breakpoints are available upon request. Females of the genotype snr1
E1
,e/TM6B,Hu,e were crossed to males harboring the mutation of interest, unless otherwise indicated. Crosses were carried out at 29°C and progeny scored for enhancement or suppression of the snr1 E1 posterior cross vein and/or L2 and L5 vein wing phenotypes, as described in the text . At least 50 wings were scored for each interaction cross. Genetic analyses involving other Brahma complex components were carried out at 25°C. P-element mobilizations were carried out using standard genetic crosses, briefly described as follows. 
Yeast two-hybrid protein interaction studies
Yeast two-hybrid interaction analyses were performed to detect protein-protein interactions using the pRF4-5o and pEG202 vectors (Finley and Brent, 1994) . Four SNR1-B42AD fusions, SNR115-370, SNR115-240, SNR1240-370, and SNR115-370 G256D have been previously described . The MOR, LSD1, and ADA2 fusions were constructed in the pEG202 vector and tested for proteinprotein interaction with the SNR1 fusions. Full-length mor and lsd1 cDNAs were obtained from the DGRC (http://dgrc.cgb.indiana.edu/) and regions of interest were amplified using standard PCR procedures (ExTaq; Takara, Inc.). Xho1/BamH1 mor fragments and EcoR1/Xho1 lsd1 and ada2a PCR fragments were independently cloned into pSK + , screened, and subcloned into the bait LexA pEG202 yeast vector. All constructs were transformed into yeast strains of opposite mating type (RFY231 and Y309), mated to produce diploids, and assayed for protein-protein interaction. A positive protein-protein interaction resulted in binding of the protein complex to an upstream activator sequence (UAS), resulting in expression of either β-galactosidase (lacZ), which results in blue colony formation on plates containing X-gal, or leu2 expression, which allows for growth on plates lacking leucine, as described previously . Each pair mating was tested in triplicate. The QuikChangeII Site-Directed Mutagenesis Kit (Stratagene) was utilized to create the specific (I350P) point mutations in snr1 sequences according to the manufacturer's protocols. Mutations were confirmed by sequencing. Primer sequences are available upon request.
RNAi in cultured S2 cells
Cultured Drosophila S2 cells were incubated with dsRNA to knockdown the endogenous snr1, mor and brm transcripts, as well as an unrelated gene CG10465, as described previously (Zraly et al., 2006) . Knock-downs were incubated for four days, then whole cell extracts prepared and protein levels assessed by Western blot using antibodies to SNR1, BRM , MOR (Mohrmann et al., 2004 ) and a control protein, CDK9. Untreated S2 cell extracts were used as a control to determine endogenous protein levels.
Co-immunoprecipitation and GST-pull down assays
Co-immunoprecipitation (Co-IP) experiments were carried out as previously described (Zraly et al., 2002 ) using extracts prepared from 0 to 24 h Oregon-R (wild type) embryos. Extracts (500 μg) were precleared with protein G-Sepharose then incubated with primary affinity purified rabbit polyclonal α-SNR1 (Zraly et al., 2002) . Protein complexes were precipitated using protein G-Sepharose beads. Bound and unbound proteins were fractionated by SDS-PAGE and analyzed by western blotting using rabbit α-LSD1 (Di Stefano et al., 2007) . The extract input (E) lane represents 20% (100 μg) of the cleared lysate used in the IP.
A full-length lsd1 cDNA was obtained from the Drosophila Genome Resource Center, (DGRC, University of Indiana, Bloomington) and regions of interest were amplified using standard PCR procedures (ExTaq; Takara, Inc.). EcoR1/Xho1 lsd1 PCR fragments were independently cloned into pSK + , screened, and subcloned into pGEX-5X1 (Stratagene). Constructs were generated that fused GST to the LSD1 N-terminal portion (SWIRM) and to the C-terminal portion (Amine Oxidase). These fusion constructs were transformed into E. coli BL21 cells, incubated at 37°C for 2 h, induced with 1 mM IPTG, and harvested 2-3 h later. The N-terminal fusion was grown at 30°C following induction, the C-terminal fusion and empty vector controls were grown at 37°C. Fusion proteins were solubilized using standard protocols and equivalent amounts of the fusion proteins as assessed by Coomassie stained gel analyses were bound to glutathione agarose beads. GST-pulldown assays were performed as described previously by incubating wild type Drosophila Oregon R embryo extracts (500 μg) with the immobilized fusion proteins or GST alone (Dingwall et al., 1995) . Bound proteins were separated by SDS-PAGE and interactions with the Brm complex were assessed by Western immunoblot using antibodies to SNR1. The extract lane contains 20% (100 μg) of the starting material.
Immunohistochemistry
Appropriately staged [stage P7, 34-42 h after pupariation (Bainbridge and Bownes, 1981) ] pupal wings were dissected, fixed, and immunostained with α-LSD1 (1:1000) antibody (a kind gift from Nicolas Dyson). Pupae were removed from pupal cases in phosphate buffered saline (PBS, pH 7.4) and fixed in 4% formaldehyde for 30 min. Pupal wings were then dissected in PBST (PBS, 0.1% Triton-X100) and removed from their cuticular envelopes. Pupal wings were washed 3× in PBST and then incubated in 10% normal goat serum (blocking) for 1 h at 4°C. Blocking solution was removed and wings were incubated with either rabbit α-LSD1 (1:1000) or PBS (negative control) at 4°C overnight. Samples were washed 4× in PBST and then incubated with goat α-rabbit-HRP (1:500) (Sigma) for 1-2 h at room temperature. Samples were again washed 3× in PBST and then developed as described previously .
Results
The Brm complex subunits SNR1 and MOR directly collaborate to regulate target genes Several lines of evidence suggest an important functional relationship between two highly conserved BRM complex components, SNR1 and MOIRA (MOR). First, the mammalian SNR1 (SNF5/ INI1/BAF47/SMARCB1) and MOR orthologs (BAF155/SRG3/SMARCC1 and BAF170/SMARCC2) are required for full BRG1 remodeling activity in vitro (Phelan et al., 1999) . Second, a physical interaction has been observed between murine SNR1 and MOR orthologs (SNF5 and SRG3) via the SRG3 SWIRM domain that is important for protein-protein interactions (Sohn et al., 2007) . Third, RNAi-mediated knockdown of snr1 and mor in cultured Drosophila S2 cells revealed nearly identical expression profiles (Sohn et al., 2007) . Finally, genetic epistasis tests in Drosophila using mutant alleles of snr1 and mor confirmed a strong in vivo interaction . This evidence suggests that SNR1 and MOR were capable of direct collaboration within the Brm complex.
The snr1 E1 mutant used in these genetic tests is a temperaturesensitive allele that behaves genetically as both a loss-of-function hypomorph and a weak dominant-negative . The mutation affects a nearly invariant glycine (G256) residue within the second repeat region, a highly conserved irregular repeat region known to be involved in multiple protein-protein interactions. Heterozygous snr1 E1 flies exhibit ectopic wing vein material perpendicular to the posterior cross vein (PCV) and anterior to longitudinal vein L2 (Fig. 1A) . The defects are apparent at the permissive (18°C) temperature, with increased penetrance at the restrictive (29°C) temperature. The phenotypes are sensitive to snr1 gene dosage and are enhanced or suppressed by mutations in other Brm complex genes, revealing that SNR1 directly regulates aspects of Brm complex activity . The mutant phenotypes result from reduced or compromised SNR1 function, rather than complete disruption of Brm complex activities as snr1 E1 produces a stable protein that is assembled into Brm complexes at both temperatures . To examine the SNR1-MOR functional relationship in more detail, we performed genetic interaction tests between snr1 E1 and several unique mor alleles (Brizuela and Kennison, 1997; Kennison and Tamkun, 1988) , as well as a small deficiency (Df(3R)Exel7327). While the original deficiency tested, Df , and COILED-COIL (CC) domains of SNR1 are indicated. Protein-protein interactions were assessed by two independent assays, the production of β-galactosidase (blue colony formation) and growth on media lacking leucine. Robust interactions were observed between the MOR SWIRM and two SNR1 fusions, SNR115-370 and SNR1240-370, both of which contained the C-terminal region, including R2 and the CC. The structure of the CC is likely not essential for the protein-protein interaction, since the SNR1I350P physically associated with the MOR SWIRM. The G256D mutation (as carried in snr1 E1 mutants) strongly interacted with the MOR SWIRM. The LexA-MOR SANT fusion served as a negative control and exhibited no interaction with SNR1(15-370). (F) Western immunoblot using extracts prepared from cultured embryonic S2 cells were treated with dsRNAs directed against snr1, mor, brm or an unrelated gene control (C) as indicated. Blots were probed with antibodies against MOR, BRM, SNR1 and a control protein, CDK9. Untreated S2 cell extracts (−) were used as a control for endogenous gene expression levels.
(3R)sbd105, is thought to completely delete mor, the endpoints of the chromosomal deletion are not well defined, and the genes predicted to be deleted in the deficiency were based on complementation analyses. Therefore, we chose to test a more accurately described deficiency (Df(3R)Exel7327) with defined endpoints that deletes mor as well as 18 other surrounding genes. Strong allele-specific enhancement of the snr1 E1 wing phenotype was observed with the deficiency (Df(3R)Exel7327) and several hypomorphic mor alleles (mor
) and a C-terminal deletion (mor 6 ) that removes the predicted leucine zipper, a motif important for homo-oligomerization ( , and mor 6 heterozygotes all display ectopic vein phenotypes, suggesting that these mutations may alter protein folding, altering the ability of MOR to regulate Brm complex activities, perhaps by changing the physical interactions it makes with the other two core complex components, SNR1 and BRM. These data confirm an important functional relationship between SNR1 and MOR in regulating Brm complex target genes. The BRM, MOR and SNR1 subunits have been proposed to function as the core components of all Brm and metazoan SWI/SNF complexes. MOR (BAF155, BAF170) has been postulated to serve as the bridge between the core subunits (Crosby et al., 1999; Moshkin et al., 2007; Phelan et al., 1999) making it likely that SNR1 regulatory functions are mediated through direct contacts with MOR. We first sought to identify a region of SNR1 essential for interacting with MOR by performing a series of yeast interaction trap analyses (Fig. 1B) . The SNR1 protein is composed of three distinct regions, two irregular repeat regions (Repeat 1 (R1) and Repeat 2 (R2)) both of which are essential for heterotypic protein-protein interactions, and a predicted Coiled-coil (CC) region also possibly involved in protein interactions (Dingwall et al., 1995; Morozov et al., 1998) . The MOR protein contains several predicted protein interaction motifs, including a leucine zipper region, SWIRM and SANT domains (Crosby et al., 1999) . We constructed several SNR1 deletion derivatives fused to the B42 activation domain and tested them for interaction with portions of MOR fused to the LexA DNA binding domain, including the SWIRM region implicated in mediating interactions between the murine homologs (Sohn et al., 2007) . A robust interaction was observed between the C-terminal portion of SNR1 (consisting of R2 and CC regions) and the MOR SWIRM region; however, we did not detect interactions between SNR1 and the SANT domain.
The COILS program (Lupas et al., 1991) predicts that amino acids 338-364 of SNR1 have approximately 50% probability of forming a Coiled-coil structure. Within this region M346, I350, M360, and A364 are likely to be involved in the formation and stability of the Coiledcoil structure, as they are located in the seam joining the two helices. We used the COILS program to predict the effects of substituting a proline for each of these residues as this change could considerably alter the alpha helical structure by forming a kink in the helices. An I350P conversion would theoretically have the most profound effect by decreasing the probability of forming a Coiled-coil to less than 1% (Supplemental Fig. 1 ). We therefore changed the I350 residue to a proline and tested the interaction with the MOR SWIRM domain using yeast two-hybrid analyses. The I350P conversion in the full-length SNR1 did not disrupt the physical association with the MOR SWIRM domain, suggesting that the formation of a Coiled-coil structure was not necessary for the observed protein interaction (Fig. 1B) .
To further ascertain whether physical associations between SNR1 and MOR were important for complex assembly or stability, we depleted SNR1, MOR and BRM in cultured Drosophila S2 cells using RNAi and tested for subunit stabilities by Western blot (Fig. 1C) . We observed reduced MOR accumulation in cells depleted for either SNR1 or BRM alone, with greater reductions of MOR in cells depleted for both SNR1 and BRM. Similarly, SNR1 levels were reduced following RNAi depletion of MOR. Thus, consistent with the widely held view that protein complex components show decreased stability when partner proteins are deleted or missing and with previous findings (Moshkin et al., 2007; Peterson and Herskowitz, 1992) , the stability of the SNR1 and MOR subunits appears to be at least partly dependent on assembly of the remodeling complex core components.
Dominant genetic modifier screens to identify SNR1-interacting coregulators
It is likely that the regulation of BRM complex activities is dependent not only upon physical associations between complex subunits, but also association of the complex with coregulatory proteins. We previously performed candidate genetic screens looking for dominant enhancement or suppression of the snr1 E1 -dependent wing phenotypes . In general, we found that loss of function mutations in vein forming genes dominantly suppressed the snr1 E1 phenotypes, while loss of function mutations in vein repressing genes showed enhancement. In order to identify factors that modify SNR1 repression functions in vivo and to identify possible coregulators of Brm complex activity, we carried out an unbiased dominant modifier genetic screen using an ordered set of chromosomal deficiencies from the Bloomington Drosophila Stock Center that removed~85% of the euchromatic genome (both X and autosomes). We looked for deficiencies that enhanced or suppressed the wing patterning phenotype associated with the temperaturesensitive snr1 E1 mutation in doubly heterozygous flies reared at 29°C.
Heterozygous snr1 E1 /+ flies display ectopic wing vein material distal to the posterior crossvein in this assay (Fig. 1A ) . Suppression was scored as an overall reduction in the penetrance of the ectopic wing vein phenotype (N20% reduction); whereas, enhancement was scored as increased penetrance (N20% increase) and/or the appearance of additional ectopic vein material. While the effects of enhancers of the snr1 E1 vein phenotype could be observed throughout the wing, the effects of suppressors were restricted to the area of the wing being examined (i.e., posterior crossvein and L5 region). In total, 88 of the~250 deficiency lines tested exhibited strong enhancement (55/88) or suppression (33/88) ( Fig. 2 ; Supplementary Tables 1-3 ). In addition, two deficiencies removing different portions of the X-chromosome exhibited heterozygous lethality in combination with snr1 E1 (Supplementary Table 1) .
As a first step towards determining whether our unbiased approach was sufficiently sensitive to identify novel Brm complexinteracting genes, we correlated the results of the deficiency screen with our earlier candidate genetic screen performed using specific mutant alleles . In general, deficiencies that removed genes previously identified as dominant enhancers of the snr1 E1 wing phenotype exhibited similar enhancement (corto, kis, Dl, bs, sbb, RpII215). There was also a correspondence between the deficiency screen results and several genes previously identified as suppressors (S, N, cycE). However, many of the enhancer and suppressor deficiencies removed loci not previously identified as interacting with the Brm complex, representing a rich resource for identifying novel coregulators of Brm complex functions. A second approach used to validate the deficiency screen results was to identify novel interacting genes (Fig. 3) . We first narrowed the interacting region(s) using either a partially overlapping deficiency or mutations in candidate genes removed by the deficiency. The heterozygous Df(3L)81k19 alone does not exhibit a wing patterning defect (Fig. 3D) ; however, the deficiency was found to dominantly enhance the snr1 E1 phenotype (Fig. 3E) . Among the genes predicted to be removed by that deficiency (http://flybase.org), the argos gene was a likely candidate, as it is a negative regulator of the EGFR pathway (Schweitzer et al., 1995) involved in wing vein specification (Marenda et al., 2006) . Heterozygotes containing a mutant argos Δ7 allele with the snr1 E1 mutation exhibited ectopic wing veins (Fig. 3F) . Similar results were obtained using a second argos mutant allele (argos 05845 ;
data not shown). The Df(2R)CX1 deficiency has no dominant heterozygous wing phenotype (Fig. 3G) ; however, in combination with snr1
E1
, we observed strong suppression of ectopic wing veins (Fig. 3H) . The E(Egfr) gene was the most likely candidate among the deduced genes removed by the deficiency. We found that a mutation in the E(Egfr)B56 gene could dominantly suppress the snr1 E1 wing patterning defect (Fig. 3I) . We can conclude that the deficiency screen approach is sufficiently sensitive to use as a first step for identifying candidate genes that may interact with the Brm complex to regulate wing patterning. Moreover, our results have indicated that the EGFR pathway may depend in part on Brm complex chromatin remodeling functions to correctly pattern the wing epithelium.
Candidate screen identifies histone demethylase enzymes as potential Brm complex coregulators
The goal of our dominant enhancer/suppressor screen was to identify novel coregulators of the Brm complex in controlling gene expression. Therefore, we looked to see if there was any functional similarity among candidate transcriptional regulators which genetically interacted with snr1 E1 . Several histone lysine demethylase enzymes (KDMs) were identified in our screen as potential mediators of Brm chromatin remodeling activities. There are two 'families' of KDMs (Klose et al., 2006; Klose and Zhang, 2007; Shi and Whetstine, 2007; Swigut and Wysocka, 2007) . The Jumonji family has 12 members and is capable of demethylating tri-, di-, and monomethylated lysine residues. A much smaller family of demethylases contains 1 member, LSD1/KDM1, which is only capable of demethylating di-, and monomethylated (H3K4) lysine residues and in mammalian cell culture analysis, di-, and monomethylated (H3K9) lysine residues when in complexes with the Androgen Receptor (AR) (Metzger et al., 2005) . We found that 7 deficiencies covering individual histone . Open bars represent deficiencies that were synthetically lethal in combination with snr1 E1 . however, the wing notching present in (H) is likely due to an unidentified interacting locus removed in the deficiency.
demethylase genes dominantly enhanced or suppressed the snr1 E1 wing patterning phenotype (Supplemental Tables 1-3) . To better determine if loss of the particular demethylase gene, and not some other gene covered by the deficiency, was responsible for the observed genetic interaction, we obtained smaller representative deficiencies for each of the 13 predicted histone demethylase genes (Klose et al., 2006; Klose and Zhang, 2007) and carried out a candidate screen by independently testing these deficiencies for a genetic interaction with snr1 E1 (Fig. 4) . We found that all 13 deficiencies tested genetically interacted; 3 deficiencies enhanced, while 10 deficiencies suppressed the snr1 E1 ectopic wing vein phenotype ( Fig. 4) , confirming that the interactions were not due simply to background effects. Our screen results provide a novel finding that in vivo Brm complex chromatin remodeling functions may be highly dependent on the activity of histone lysine demethylase enzymes.
LSD1 genetically interacts with Brm complex components
The Brm complex has important roles in regulating gene transcription, in part by physically associating with transcription activator proteins (Gutierrez et al., 2007; Hassan et al., 2001; Neely et al., 2002) as well as RNA Polymerase II (Armstrong et al., 2002) , gene repressor proteins Sudarsanam et al., 2000) , and alternative splicing factors (Batsche et al., 2006; Tyagi et al., 2009) . While much work has focused on understanding how , the candidate gene did not, suggesting that the interaction with the deficiency was either due to loss of an unknown gene and not from loss of the histone demethylase, or that the particular demethylase allele tested was weak.
k Opposite genetic interactions were observed with the deficiency and the candidate gene. (Fig. 5E) . It was previously demonstrated that a heterozygous brm 2 mutation suppressed the ectopic vein phenotype associated with heterozygous snr1 E1 . Therefore, 5F,G; Table 2 ). The lsd1 ΔN allele also demonstrated strong allelespecific interaction with various mor mutants (Fig. 5, Table 3 ). For example, the double heterozygous combination of lsd1 ΔN with mor 1 , a loss of function point mutation (Fig. 5H) , leads to the appearance of ectopic posterior crossveins by more than 50% (Fig. 5I) . These data suggest that some aspects of SNR1-dependent repression of Brm functions in the wing intervein region depend on a fully functional LSD1.
LSD1 associates with Brm complexes containing POLYBROMO/BAP180 and BAP170 (PBAP) but not OSA (BAP)
The SWI/SNF family of remodeling complexes can be divided into two subclasses that have the same constellation of core subunits, with differences in signature subunit composition (Mohrmann and Verrijzer, 2005) . In Drosophila, BAP complexes contain OSA as a signature subunit while PBAP complexes contain POLYBROMO/ BAP180, BAP170 and SAYP but not OSA (Chalkley et al., 2008; Collins and Treisman, 2000; Mohrmann et al., 2004; Moshkin et al., 2007) . Genetic studies have revealed pathway-specific regulation of target genes by each of these Brm complex subclasses. Therefore, we tested if lsd1
ΔN displayed a preferential genetic interaction with mutations in osa, polybromo (Bap180), or Bap170 (Carrera et al., 2008) . We observed no genetic interaction (Fig. 5K) between lsd1 ΔN and a loss of function osa mutant (osa 00090 ) Treisman et al., 1997; Vazquez et al., 1999) in the context of wing pattern development. However, lsd1
ΔN interacted strongly with null alleles Table 3 ), suggesting that LSD1 corepressor functions may be targeted to PBAP-specific wing development pathways.
LSD1 physically associates with the Brm complex
LSD1 is not a component of purified Brm complexes (Papoulas et al., 1998) ; therefore, the observed genetic interactions may be either direct or indirect. We addressed whether LSD1 could physically associate with the Brm complex by using in vivo coimmunoprecipitation and GST-pulldown assays. Drosophila embryo extracts were immunoprecipitated with antibodies directed against the SNR1 subunit, as it is a stable core component of purified Brm complexes (Papoulas et al., 1998; Zraly et al., 2004 Zraly et al., , 2003 . LSD1 was found to reside in the precipitated material (Fig. 6A) , indicating that LSD1 could associate with the Brm complex in vivo. To help verify the interaction we fused N-and C-terminal portions of Drosophila LSD1 to GST and tested for Brm complex associations using an in vivo pulldown assay (Fig. 6B) . Wild type embryo extracts were incubated with equivalent amounts of purified GST alone, GST:LSD1-N (aa1-255) and GST:LSD1-C (aa258-876) fusions immobilized on glutathione agarose. Complexes were tested for the presence of SNR1 and only the GST:LSD1-N fusion containing the SWIRM domain was found to interact. There was no detectable interaction with the LSD1 amine oxidase domain that is essential for the demethylase activity, suggesting that the LSD1 SWIRM domain is sufficient for interaction with the Brm complex in vivo.
LSD1 has an important role in wing development LSD1 exhibits both genetic and protein interaction with components of the Brm chromatin remodeling complex, suggesting that LSD1 might have an important role in wing pattern formation in cooperation with Brm functions. We previously found that the Brm complex is widely expressed in wing tissues during the early pupal stage that corresponds to the developmental period when the cross veins are forming . Similarly, LSD1 is expressed uniformly throughout the developing pupal wing, in both vein and intervein cells (Figs. 7A,B ) which is consistent with a broad role in regulating the expression of genes required for proper wing vein development.
In order to better understand the relationship between LSD1 and the Brm complex, we employed a tissue-specific knockdown of lsd1 in the developing wing using the GAL4-UAS system (Bernstein et al., 2001 ). Short hairpin-RNAi (shRNAi) constructs, also known as inverted repeats (IR), were expressed in a tissue specific manner to deplete lsd1 mRNA. Expression of an lsd1-IR using the GawB69B GAL4 imaginal disc driver led to ectopic veins anterior to the L2 longitudinal vein and along the posterior crossvein (Fig. 7C) , a phenotype similar to the effects of losing Brm complex repressor functions. The penetrance and expressivity of the knockdown phenotype was greater in males as well as flies reared at 29°C, and enhanced by the addition of a UAS-Dicer transgene that amplifies the RNAi effect (Bernstein et al., 2001; Dietzl et al., 2007) . UAS-Dicer; lsd1-IR/GawB69B males displayed the strongest phenotypes including crumpled, broken and held-out wings (Fig. 7B and data not shown) .
Wing veins develop as a consequence of specific signaling pathways that are restricted to subsets of cells within the wing primordium (Bier, 2000) . The Brm complex contributes to the development of the veins through activation functions in vein cells and suppression of those pathways in the intervein cells . To help determine whether LSD1 cooperates with the Brm complex in restricting vein development in a cell-specific manner, we expressed the lsd1-IR in wing intervein cells through the use of a blistered-GAL4 driver. Blistered (BS) is homologous to mammalian serum response factor and the expression of BS is restricted to intervein cells in the developing Drosophila wing (Johannes and Preiss, 2002) . We found that loss of lsd1 in intervein cells resulted in ectopic vein formation including an ectopic anterior cross vein (ACV) in a small percentage of animals (Fig. 7E) . This data supports the view that LSD1 functions to repress wing vein formation in intervein cells, possibly by cooperating with the Brm complex to restrict vein-specific gene transcription. Wild type embryo extracts (500 μg) were immunoprecipitated with antibodies to SNR1. Proteins from whole extracts (E, 100 μg), supernatant (S), and pellet (P) were fractionated by SDS-PAGE and transferred to a nitrocellulose membrane. Western blots were probed with anti-LSD1 antibody. (B) LSD1 SWIRM domain interacts with the Brm complex. GST-LSD1 fusions were generated that contained either the SWIRM domain (LSD1-N) or the amine oxidase domain (LSD1-C) and used for pull-down experiments. Similar amounts of immobilized GST fusions were incubated with whole embryo extracts (500 μg) and interactions with the Brm complex were assessed by immunoblot analyses using anti-SNR1 antibody. Extract lane represents 100 μg of embryo lysate.
Discussion
Although chromatin remodeling is an important component of gene activation, its role in gene repression is not as well understood. Our unbiased genetic screen using a weak dominant temperature sensitive mutant allele of a key Brm complex regulatory subunit has provided new insights into the involvement of chromatin remodeling complexes in developmental tissue patterning. We found that mutations in components of several signaling pathways, including Notch, EGFR and DPP/TGFβ, genetically interacted in our assay. These results, combined with candidate gene genetic analyses (this study , have confirmed our previous hypotheses that the Brm complex participates in both gene activation and gene repression to help coordinate several key signaling pathways that lead to proper animal patterning. Our results are largely concordant with the results of previous limited screens that identified a set of dominant modifiers of brm K804R mutant phenotypes (Armstrong et al., 2005; Papoulas et al., 1998) . Among 14 chromosomal deficiencies that enhanced the brm K804R rough eye phenotype, we found that 6/14 were also dominant enhancers of the snr1 E1 wing phenotype and 3/14 were suppressors (Tables S2, S3 ), suggesting that dominant modifier screens are effective tools for identifying unknown loci important for Brm complex regulatory functions. Consistent with this view, the Brm complex has been shown to interact the Notch ligand, Delta, in the developing fly eye (Armstrong et al., 2005) . Our genetic modifier screen results presented here indicate that Notch signaling functions may also be mediated through the Brm complex in the developing fly wing. Given the strong evolutionary conservation of these pathways, we anticipate that the vertebrate SWI/SNF orthologs will play a similarly important role in patterning the tissues of vertebrate animals. What are the target genes regulated by the Brm complex in the developing wing? We previously found that loss of snr1 function results in ectopic dpp and rhomboid expression in intervein cells . These data are consistent with the genetic interactions shown in this report that were observed using mutants affecting both the DPP and EGFR pathways. Our studies have additionally provided an important insight into gene regulatory factors beyond signaling pathways that contribute to transcription repression in collaboration with chromatin remodeling complexes at key points in the development and differentiation of tissues. In our present analyses, we provide several lines of evidence suggesting that the mechanism of Brm complex-mediated gene repression is not only dependent upon a tight, physical and genetic relationship between two core subunits, SNR1 and MOR, but also on histone lysine demethylase enzymes.
MOR has an important role in regulating Brm complex stability and facilitating SNR1 repressor functions It has been reported that the full in vitro chromatin remodeling activity of the mammalian BRM/BRG1 complex on reconstituted nucleosomes can be accomplished with a subset of three or four core components, including the SNF5 (SNR1), BAF155/BAF170 (MOR) and BRM/BRG1 ATPase subunits that are highly conserved from yeast to vertebrates (Phelan et al., 1999) . Each of these subunits is required for complex stability in vivo as RNAi depletion of the individual components in cultured Drosophila cells leads to reduced stability of the other subunits with corresponding changes in target gene expression (this study and Moshkin et al., 2007; Zraly et al., 2006) . Loss of BRM function in vivo, using either a dominant negative ATPase deficient mutant (brm K804R ) or an amorphic allele (brm 2 ), can suppress the snr1 E1 wing phenotype revealing an important role for SNR1 in restraining Brm complex transcription activation functions. In contrast, mor mutants enhance mutant phenotypes associated with reduced brm function (Brizuela and Kennison, 1997) and show allele-specific interaction with snr1 E1 , suggesting an important functional relationship between the MOR, BRM and SNR1 subunits. MOR likely serves as a scaffolding protein, since physical associations were observed between SNR1-MOR and MOR-BRM. Two independent domains of MOR, the SWIRM and SANT, domains respectively, are critical for the binding interaction (Crosby et al., 1999; Moshkin et al., 2007; Phelan et al., 1999) . Therefore, the contribution of SNR1 regulatory function on Brm complex chromatin remodeling activities may depend on crosstalk through MOR since no direct physical contacts between SNR1 and the BRM subunit have been observed.
Histone demethylase enzymes function as coregulators of the Brm complex
An unbiased dominant modifier genetic screen allowed us to identify histone lysine demethylase enzymes as novel coregulators of the Brm complex in controlling gene expression. Previous screens looking for modifiers of a brm dominant negative allele (brm
K804R
) did not uncover mutations in histone-modifying families, such as acetyltransferases, deacetylases, and methyltransferases (Armstrong et al., 2005) . However, the wing patterning defect associated with snr1 E1 is highly sensitive, allowing us to observe subtle changes in remodeling activities, and identify a family of epigenetic modifiers as potential Brm regulators. We previously found that histone deacetylases (HDACs) were important corepressors that worked in direct collaboration with the Brm complex Zraly et al., 2004) . In the present study, mutations in predicted demethylase genes genetically interacted with snr1 E1 and LSD1 was shown to associate with the Brm complex in vivo, suggesting demethylases are also potential cofactors. While a functional cooperation between histone deacetylation and demethylation activities has been suggested (Lan et al., 2008; Lee et al., 2006) , our data implicates at least three chromatin modifying activities-ATP-dependent chromatin remodeling, histone deacetylation and demethylation-cooperating to regulate tissue-specific gene repression through multiple bridging interactions. In this scenario, the commitment of a gene promoter to be repressed in a cell type-specific manner would depend on the collateral influence of several chromatin modifying activities that would serve to help establish a repressed transcriptional environment, refractory to the influence of signaling pathways operational in adjacent cells. There appears to be no correlation between the predicted demethylase lysine substrate and enhancement/suppression of the snr1 E1 phenotype. This is not surprising, since a high degree of functional redundancy exists amongst demethylase enzymes Kouzarides, 2007; Shi and Whetstine, 2007) . It is likely that multiple demethylase enzymes cooperate to regulate a variety of target genes. This is supported by experimental evidence showing that knockdown experiments of individual demethylases, for example lsd1, in cell culture often showed little or no change in global methylation status, though significant changes were observed on a gene-specific level in vivo (Di Stefano et al., 2007; Rudolph et al., 2007) . Independent loss of function mutations in two JARID family members, lid and Jarid2/CG3654, resulted in an opposite genetic interaction with snr1
E1
. We observed that a loss of function mutation in lid, (lid 2 ) dominantly suppressed, whereas a loss of function mutation in Jarid2 (CG3654 EY02717 ) enhanced the ectopic vein phenotype associated with snr1
. LID is an H3K4me3/me2 specific demethylase Lloret-Llinares et al., 2008; Secombe et al., 2007) . JARID2 is predicted to have the same substrate specificity, though overexpression analyses in cell culture experiments showed no global increase in H3K4me3/2 (Lloret- Llinares et al., 2008) . The observed opposite genetic interaction with snr1 E1 may reflect differences in target gene regulation by LID and JARID2, either as a consequence of different target genes controlled in the developing wing or through opposite mechanisms in controlling gene transcription. Importantly, JARID2 homologs in Xenopus and mammalian model systems physically associate with the Polycomb Repressor Complex-2 (PRC2) and directly contribute to transcriptional repression by preventing the methylation of the histone lysine residues correlated with transcriptional activation (Li et al., 2010; Pasini et al., 2010; Peng et al., 2009; Shen et al., 2009 ) Therefore, mutation of JARID2 (CG3654
EY02717
) may enhance the snr1 E1 phenotype if the normal role of CG3654 is to suppress transcription of a particular gene involved in wing vein development. The cell-fate decision to become vein or intervein is largely based on cell-type specific expression of transcription factors (Blair, 2007; de Celis, 2003) . In vein cells, transcription factors with gene targets that promote vein development are highly expressed, whereas those with gene targets that block vein fate are repressed. In intervein cells, the opposite is observed, with heightened expression interveinpromoting factors and decreased expression of vein promoting factors. The Brm complex has an important role in development of both cell fates, serving a positive role to promote vein development in vein cells, and repress vein development in intervein cells . The opposite genetic interaction phenotypes observed with lid and Jarid2 could be partially explained if the Brm complex is coordinating with the each specific demethylase to regulate different target genes. We found that loss of function mutations in vein promoting genes, such as Egfr, suppressed the snr1 E1 phenotype .
LSD1 may be a cofactor specific to the PBAP family of Brm complexes
Our candidate genetic screen results suggest that histone lysine demethylase enzymes are likely cofactors of Brm chromatin remodeling activity. However, it is highly unlikely that stable physical associations are made between the complex and all six demethylases. We cannot eliminate the possibility that the Brm complex and demethylase enzymes are independently regulating genes involved in wing patterning or eliciting their functions on different targets at different times during development to contribute to the final read-out of vein/intervein patterning in the adult wing. However, we did observe a direct physical association between the Brm complex and LSD1 in coimmunoprecipitation and GST-pulldown experiments, implying that LSD1 is a potential cofactor of Brm complex remodeling activities.
Our genetic epistasis experiments demonstrated an important in vivo functional relationship between LSD1 and the core subunits of the Brm complex, SNR1, MOR, and BRM. Brm complexes can be subdivided into two groups: PBAP complexes contain BAP170, POLYBROMO/BAP180, and SAYP, whereas BAP complexes contain OSA (Chalkley et al., 2008; Collins et al., 1999; Kal et al., 2000; Mohrmann et al., 2004; Papoulas et al., 1998) . These complexes can regulate target genes in a synergistic, antagonistic, or independent manner (Mohrmann et al., 2004; Moshkin et al., 2007) . BAP and PBAP complexes likely have differential regulatory functions, since they have distinct, but overlapping, localization patterns on larval salivary gland polytene chromosomes (Mohrmann et al., 2004) and targeted knockdown of OSA, POLYBROMO, or BAP180 using RNAi in cultured Schneider cells, leads to differential expression profiles on whole genome arrays (Moshkin et al., 2007) . OSA, BAP170, BAP180, and SAYP likely have different roles in development, as mutation of each leads to different abnormalities. For example, BAP180 is required for proper egg shell development, whereas BAP170 is necessary to stabilize BAP180, important for adult viability, and vein cell differentiation (Carrera et al., 2008) . OSA is necessary for photoreceptor development, normal embryonic segmentation, and wing patterning (Treisman et al., 1997) . BAP, but not PBAP complexes have an important role in regulating cell cycle progression through mitosis (Moshkin et al., 2007) .
In mice, knockout of Baf180 causes misregulation of retinoic acid receptor target genes and heart developmental defects, indicating that PBAP complexes may have a role in nuclear receptor transcriptional regulation (Wang et al., 2004) . The LSD1 corepressor complex, including the cofactor proteins, CoREST, and histone deacetylase, HDAC1/2, have also been indicated in nuclear receptor transcriptional regulation. LSD1 association in complexes containing the Estrogen Receptor (ER) or Androgen Receptor (AR) leads to a switch in methylated lysine specificity, and results in demethylation of monoand dimethylated H3K9 and gene activation Metzger et al., 2005) .
It is not known how BAP vs. PBAP complexes are differentially recruited to target genes. Recruitment of BAP complexes to specific target genes may depend on the physical associations made by OSA and sequence-specific transcription factors. For example, OSA is required for expression of target genes associated with the transcription factors Pannier and Apterous (Milan et al., 2004) and can promote transcriptional repression of genes regulated by Wnt/ Wingless signaling (Collins et al., 1999; Collins and Treisman, 2000) . Our genetic epistasis experiments reveal that LSD1 cooperates with PBAP, but not BAP containing complexes in the Drosophila wing, suggesting that the physical association we observed between LSD1 and Brm complex may be limited to PBAP complexes and provide a mechanism for selective target gene recruitment and regulation by Brm remodeling complexes. Further analyses, such as GST-pulldown and coimmunoprecipitation experiments using PBAP specific components need to be performed to address this possibility.
LSD1 has cell type-specific role to repress vein cell differentiation Ectopic vein development within intervein tissue can result from two different possibilities: 1) the loss of a factor necessary to block vein cell development, or 2) the gain of a factor that promotes vein cell differentiation. Our knockdown experiments suggest LSD1/dCoREST functions through the first mechanism. Loss of LSD1/dCoREST throughout the entire developing wing imaginal disc resulted in the development of vein material in intervein tissue, but no changes in vein morphology were observed. If LSD1/dCoREST normally functioned to promote vein development, then loss throughout the entire wing should have led to a loss of vein phenotype.
Several lines of evidence suggest that LSD1 may be capable of regulating gene transcription in a cell-type or stage dependent manner. The affect of homozygous loss of lsd1 on transcriptional regulation of known target genes, including the Sodium Channel and Nicotinic Acetylcholine Receptor-β is minimal in embryos and larvae, but significant in pupae (Di Stefano et al., 2007) . This implies that LSD1 has an important role in regulating gene transcription during later developmental stages. Moreover, LSD1 negative regulation of the homeobox genes, Ultrabithorax (Ubx) and abdominal-B (abd-B) continues into adulthood, as lsd1 null animals display significantly increased expression of these genes as the animals continue to age (Di Stefano et al., 2007) . This stage-dependent requirement appears to be conserved, as the conditional knock-out of LSD1 in the developing mouse pituitary gland causes little or no morphological defects early in pituitary development (E9-9.5), but significantly alters cell-fate determination choices during later stages (E17.5) .
Furthermore, LSD1 mediates both gene activation and gene repression of different target genes by associating with several multisubunit complexes (Lan et al., 2008; Wang et al., 2007) .
Our knockdown and genetic epistasis experiments further support the idea that LSD1 is important for regulating terminal differentiation, since patterning phenotypes are similar to those observed with defects in DPP and EGFR signaling, the pathways active during pupal development, rather than observed with defects in HH signaling, an early pathway component. Previous work has demonstrated an important role in Brm complex involvement in EGFR, DPP, and Delta/N signaling (Armstrong et al., 2005; Marenda et al., 2004) . More recently, it has been demonstrated that OSA, the defining subunit of the BAP complex, is required to activate EGFR targets in the developing wing (Terriente-Félix and de Celis, 2009) . In this regard, the Brm complex may be cooperating with LSD1 to regulate several conserved signaling pathways, but this cooperation may be tissue and developmental time-point dependent.
Supplementary materials related to this article can be found online at doi:10.1016/j.ydbio.2010.12.001.
